Neoadjuvant Chemotherapy for Resectable Non-Small Cell Lung Cancer

, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873

Zhen Zhou, Bao-hui Han, Hao Ji, Guo-xing Ni, Jia-an Ding, Wen-hu Chen, Yun-zhong Zhou, Zhi-wei Chen, Jia-mei Zhao, Mei-lin Liao, Jie Shen, Hui-min Wang, Hao Bai, [The study of peri-operative chemotherapy in stage I-IIIa NSCLC]. National Medical Journal of China. ,vol. 83, pp. 962- 966 ,(2003)

K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880

W Eberhardt, H Wilke, G Stamatis, M Stuschke, A Harstrick, H Menker, B Krause, M R Müeller, M Stahl, M Flasshove, V Budach, D Greschuchna, N Konietzko, H Sack, S Seeber, Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. Journal of Clinical Oncology. ,vol. 16, pp. 622- 634 ,(1998) , 10.1200/JCO.1998.16.2.622

Wei-An Song, Nai-Kang Zhou, Wei Wang, Xiang-Yang Chu, Chao-Yang Liang, Xiao-Dong Tian, Jun-Tang Guo, Xi Liu, Yang Liu, Wei-Min Dai, Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials Journal of Thoracic Oncology. ,vol. 5, pp. 510- 516 ,(2010) , 10.1097/JTO.0B013E3181CD3345

Jack A Roth, E.Neely Atkinson, Frank Fossella, Ritsuko Komaki, M.Bernadette Ryan, J.B Putnam, Jin Soo Lee, Hari Dhingra, Louis De Caro, Marvin Chasen, Waun Ki Hong, Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer. ,vol. 21, pp. 1- 6 ,(1998) , 10.1016/S0169-5002(98)00046-4

Bertrand Dautzenberg, Jacques Benichou, Philippe Allard, Bernard Lebeau, Daniel Coetmeur, Jeanne-Marie Brechot, Marie J. Postal, Claude Chastang, Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma results from a randomized phase II trial Cancer. ,vol. 65, pp. 2435- 2441 ,(1990) , 10.1002/1097-0142(19900601)65:11<2435::AID-CNCR2820651105>3.0.CO;2-2

A.D. Elias, A.T. Skarin, T. Leong, S. Mentzer, G. Strauss, T. Lynch, L. Shulman, C. Jacobs, A. Abner, E.H. Baldini, E. Frei, D.J. Sugarbaker, Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC) Lung Cancer. ,vol. 17, pp. 147- 161 ,(1997) , 10.1016/S0169-5002(97)00658-2

Jocelyne Martin, Robert J Ginsberg, Amir Abolhoda, Manjit S Bains, Robert J Downey, Robert J Korst, Tracey L Weigel, Mark G Kris, Ennapadam S Venkatraman, Valerie W Rusch, Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy The Annals of Thoracic Surgery. ,vol. 72, pp. 1149- 1154 ,(2001) , 10.1016/S0003-4975(01)02995-2

D C Betticher, , S-F Hsu Schmitz, M Tötsch, E Hansen, C Joss, C von Briel, R A Schmid, M Pless, J Habicht, A D Roth, A Spiliopoulos, R Stahel, W Weder, R Stupp, F Egli, M Furrer, H Honegger, M Wernli, T Cerny, H-B Ris, Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study British Journal of Cancer. ,vol. 94, pp. 1099- 1106 ,(2006) , 10.1038/SJ.BJC.6603075